Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
作者： Dan Ziegler , Phillip A. Low , William J. Litchy , Andrew J.M. Boulton , Aaron I. Vinik
DOI: 10.2337/DC11-0503
关键词:
摘要: … to oral treatment with 600 mg ALA once daily (n = 233) or … of two Neuropathy Impairment Score (NIS) points (16,17). Therefore, we assessed the efficacy and safety of oral treatment with …
diabetesjournals.org
elsevier.com
harvard.edu
manchester.ac.uk参考文章(25)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 358, pp. 2560- 2572 ,(2008) , 10.1056/NEJMOA0802987
Dan Ziegler, Dieter Luff, Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities? International Review of Neurobiology. ,vol. 50, pp. 431- 463 ,(2002) , 10.1016/S0074-7742(02)50085-4
Eun Hee Koh, Woo Je Lee, Sang Ah Lee, Eun Hee Kim, Eun Hee Cho, Eunheui Jeong, Dong Woo Kim, Min-Seon Kim, Joong-Yeol Park, Keun-Gyu Park, Hyo-Jung Lee, In-Kyu Lee, Soo Lim, Hak Chul Jang, Ki Hoon Lee, Ki-Up Lee, Effects of Alpha-Lipoic Acid on Body Weight in Obese Subjects The American Journal of Medicine. ,vol. 124, pp. 85- ,(2011) , 10.1016/J.AMJMED.2010.08.005
D. Ziegler, W. Rathmann, T. Dickhaus, C. Meisinger, A. Mielck, , Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy The MONICA/KORA Augsburg Surveys S2 and S3 Diabetes Care. ,vol. 31, pp. 464- 469 ,(2008) , 10.2337/DC07-1796
Aaron I Vinik, Vera Bril, Peter Kempler, William J Litchy, Solomon Tesfaye, Karen L Price, Edward J Bastyr III, MBBQ Study Group, Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial Clinical Therapeutics. ,vol. 27, pp. 1164- 1180 ,(2005) , 10.1016/J.CLINTHERA.2005.08.001
W. Rathmann, B. Haastert, B. Delling, F. A. Gries, G. Giani, Postmarketing surveillance of adverse drug reactions: a correlational study approach using multiple data sources. Pharmacoepidemiology and Drug Safety. ,vol. 7, pp. 51- 57 ,(1998) , 10.1002/(SICI)1099-1557(199801/02)7:1<51::AID-PDS319>3.0.CO;2-B
Peter James Dyck, Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle & Nerve. ,vol. 11, pp. 21- 32 ,(1988) , 10.1002/MUS.880110106
Zbyněk Šidák, Rectangular Confidence Regions for the Means of Multivariate Normal Distributions Journal of the American Statistical Association. ,vol. 62, pp. 626- 633 ,(1967) , 10.1080/01621459.1967.10482935
D. Ziegler, A. Ametov, A. Barinov, P. J. Dyck, I. Gurieva, P. A. Low, U. Munzel, N. Yakhno, I. Raz, M. Novosadova, J. Maus, R. Samigullin, Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy The SYDNEY 2 trial Diabetes Care. ,vol. 29, pp. 2365- 2370 ,(2006) , 10.2337/DC06-1216
Kenneth F. Schulz, CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials Annals of Internal Medicine. ,vol. 152, pp. 726- 732 ,(2010) , 10.7326/0003-4819-152-11-201006010-00232